Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
75254-3 Do you have difficulty communicating, reading, or do you have limited proficiency in English Find ^Patient Pt Ord HHS.ACA Section 4302.ONC   TRIAL Do you have difficulty communicating, reading, or do you have limited proficiency in English [HHS.ACA Section 4302.ONC]   MIN DefinitionDescription                   SURVEY.HHS   75254-3   HHS.ACA Section 4302.ONC     Observation       0       Do you have difficulty communicating, reading, or do you have limited proficiency in English?     Department of Health and Human Services, Affordable Care Act Section 4302; Department of Health and Human Services, Affordable Care Act Section 4302 and Office of the National Coordinator for Health Information Technology (ONC); Finding; Findings; HHS.ACASec4302; HHS.ACASec4302.ONC; LMTED; LTD; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.HHS 2.48 2.48       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
75255-0 Assistance needed Find ^Patient Pt Nom HHS.ACA Section 4302.ONC   TRIAL Assistance needed [HHS.ACA Section 4302.ONC]   MIN DefinitionDescription                   SURVEY.HHS   75255-0   HHS.ACA Section 4302.ONC     Observation       0       If so, what assistance may you need?     Department of Health and Human Services, Affordable Care Act Section 4302; Department of Health and Human Services, Affordable Care Act Section 4302 and Office of the National Coordinator for Health Information Technology (ONC); Finding; Findings; HHS.ACASec4302; HHS.ACASec4302.ONC; Nominal; Point in time; Random; Survey; SURVEY.HHS 2.48 2.48       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
75256-8 Disability information & assistance needed panel - ^Patient Pt - HHS.ACA Section 4302.ONC   TRIAL Disability information and assistance needed panel [HHS.ACA Section 4302.ONC]   MIN DefinitionDescription                   PANEL.SURVEY.HHS   75256-8   HHS.ACA Section 4302.ONC     Order       0             Department of Health and Human Services, Affordable Care Act Section 4302; Department of Health and Human Services, Affordable Care Act Section 4302 and Office of the National Coordinator for Health Information Technology (ONC); HHS.ACASec4302; HHS.ACASec4302.ONC; Pan; PANEL.SURVEY.HHS; Panl; Pnl; Point in time; Random; Survey; SURVEY.HHS 2.48 2.48   Panel   AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
75257-6 Marital status Type ^Mother Pt Nom CDC.CS   ACTIVE Mother's Marital status [CDC.CS]   MIN DefinitionDescription                   SURVEY.CDC   75257-6   CDC.CS     Observation       0     CS.15       Centers for Disease Control and Prevention; Centers for Disease Control Congenital Syphilis (CS) Case Investigation and Report; Mat; Maternal; Matnl; Nominal; Point in time; Random; Survey; SURVEY.CDC; Typ 2.48 2.48                       0
75258-4 PROMIS short form - sleep disturbance 4a - version 1.0 - ^Patient Pt - PROMIS   ACTIVE PROMIS short form - sleep disturbance 4a - version 1.0   MIN DefinitionDescription         Copyright Ã?© 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx         PANEL.SURVEY.PROMIS   75258-4   PROMIS     Order       0             Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS 2.52 2.48   Panel     Copyright Ã?© 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx             0
75259-2 PROMIS short form - pain intensity 3a - version 1.0 - ^Patient Pt - PROMIS   ACTIVE PROMIS short form - pain intensity 3a - version 1.0   MIN DefinitionDescription         Copyright Ã?© 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx         PANEL.SURVEY.PROMIS   75259-2   PROMIS     Order       0             Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS 2.52 2.48   Panel     Copyright Ã?© 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx             0
7526-7 Nigrospora sphaerica Ab.IgE ACnc Ser Pt Qn     ACTIVE Nigrospora sphaerica IgE Ab [Units/volume] in Serum   MIN DefinitionDescription     kIU/L             ALLERGY   7526-7         Both       0 N sphaerica IgE Qn       Y   ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; N sphaerica; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR 2.73 1.0h(2)               k[IU]/L       0
75260-0 What is your level of pain right now Find ^Patient Pt Ord PROMIS   ACTIVE What is your level of pain right now [PROMIS]   MIN DefinitionDescription         Copyright Ã?© 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx         SURVEY.PROMIS   75260-0   PROMIS     Observation       0     PAINQU21 What is your level of pain right now?     Finding; Findings; Levels; Levl; LV; LVL; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; R; Random; RT; Screen; Survey; SURVEY.PROMIS 2.65 2.48         Copyright Ã?© 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx             0
75261-8 How intense was your average pain in the past 7D Find ^Patient 7D Ord PROMIS   ACTIVE How intense was your average pain in the past 7 days [PROMIS]   MIN DefinitionDescription         Copyright Ã?© 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx         SURVEY.PROMIS   75261-8   PROMIS     Observation       0     PAINQU8 In the past 7 days - How intense was your average pain?     Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS 2.65 2.48         Copyright Ã?© 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx             0
75262-6 How intense was your pain at its worse in the past 7D Find ^Patient 7D Ord PROMIS   ACTIVE How intense was your pain at its worse in the past 7 days [PROMIS]   MIN DefinitionDescription         Copyright Ã?© 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx         SURVEY.PROMIS   75262-6   PROMIS     Observation       0     PAINQU6 In the past 7 days - How intense was your pain at its worst?     Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS 2.65 2.48         Copyright Ã?© 2010 PROMIS Health Organization or other individuals/entities that have contributed information and materials to Assessment Center, and are being used with the permission of the copyright holders. Use of PROMIS instruments (e.g., item banks, short forms, profile measures) are subject to the PROMIS Terms and Conditions available at: http://www.assessmentcenter.net/TandC.aspx             0
75263-4 Blood group antibody PrThr Ser/Plas Pt Ord Blood group antibody screen.GEL   ACTIVE Blood group antibody screen [Presence] in Serum or Plasma by GEL   NAM DefinitionDescription                   BLDBK   75263-4   Blood group antibody screen.GEL     Both       0 Bld gp Ab Scn SerPl Ql GEL           Ab; Bld gp Ab Scn; BLOOD BANK; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.79 2.48                     Release 2.79: COMPONENT: Triggered by Coll w SCT: Screen should be omitted from Component. It should be in Method.; Previous Releases: The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
75264-2 Blood group antibody PrThr Ser/Plas Pt Ord Blood group antibody screen.LISS   ACTIVE Blood group antibody screen [Presence] in Serum or Plasma by Low ionic strength saline (LISS)   NAM DefinitionDescription                   BLDBK   75264-2   Blood group antibody screen.LISS     Both       0 Bld gp Ab Scn SerPl Ql LISS           Ab; Bld gp Ab Scn; BLOOD BANK; Low ionic strength saline; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.79 2.48                     Release 2.79: COMPONENT: Triggered by Coll w SCT: Screen should be omitted from Component. It should be in Method.; Previous Releases: The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
75265-9 Blood group antibody PrThr Ser/Plas Pt Ord Blood group antibody screen.PEG   ACTIVE Blood group antibody screen [Presence] in Serum or Plasma by Polyethylene glycol (PEG) method   NAM DefinitionDescription                   BLDBK   75265-9   Blood group antibody screen.PEG     Both       0 Bld gp Ab Scn SerPl Ql PEG           Ab; Bld gp Ab Scn; BLOOD BANK; Ordinal; Pl; Plasma; Plsm; Point in time; Polyethylene Glycol; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.79 2.48                     Release 2.79: COMPONENT: Triggered by Coll w SCT: Screen should be omitted from Component. It should be in Method.; Previous Releases: The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
75266-7 Glutarylcarnitine (C5-DC)/Octanoylcarnitine+Decanoylcarnitine (C8+C10) SRto Bld.dot Pt Qn     ACTIVE Glutarylcarnitine (C5-DC)/Octanoylcarnitine+Decanoylcarnitine (C8+C10) [Molar ratio] in DBS   MIN DefinitionDescription     ratio             CHEM   75266-7         Both       0 Glutarylcarn/C8+C10 DBS-sRto           Blood; C5DC; C5-DC; Chemistry; DBS; Dicarboxylic carnitine; Dried blood spot; Filter paper; FP; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; WB; Whole blood 2.61 2.48               {Ratio}       0
75267-5 Glutarylcarnitine (C5-DC)/Palmitoylcarnitine (C16) SRto Bld.dot Pt Qn     ACTIVE Glutarylcarnitine (C5-DC)/Palmitoylcarnitine (C16) [Molar ratio] in DBS   MIN DefinitionDescription     ratio             CHEM   75267-5         Both       0 Glutarylcarn/C16 DBS-sRto           Blood; C16; C5DC; C5-DC; Chemistry; DBS; Dicarboxylic carnitine; Dried blood spot; Filter paper; FP; Hexadecanoylcarnitine; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; WB; Whole blood 2.61 2.48               {Ratio}       0
75268-3 Leucine/Phenylalanine SRto Bld.dot Pt Qn     ACTIVE Leucine/Phenylalanine [Molar ratio] in DBS   MIN DefinitionDescription     ratio             CHEM   75268-3         Both       0 Leucine/Phe DBS-sRto           Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Leu; Phe; PKU; Point in time; PPA; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; WB; Whole blood 2.61 2.48               {Ratio}       0
75269-1 Bacteria Prid Genital Pt Nom Anaerobic+Aerobic culture   ACTIVE Bacteria identified in Genital specimen by Anaerobe+Aerobe culture   NAM DefinitionDescription                   MICRO   75269-1   Anaerobic+Aerobic culture     Observation       0 Bacteria Genital Anaerobe+Aerobe Cult           Aerobe; Aerobe Cult; Aerobed; Anaerobe+Aerobe Cult; Bact; C&S; Cult; Cultures; Gen; Genital tract; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; Urogenit; Urogenital 2.78 2.48                     Release 2.78: COMPONENT: Removed "Identified" from the component because it is implied by the Property "Prid"; 0
7527-5 Nutmeg Ab.IgG ACnc Ser Pt Qn     ACTIVE Nutmeg IgG Ab [Units/volume] in Serum   MIN DefinitionDescription                   ALLERGY   7527-5         Both       0 Nutmeg IgG Qn       Y   ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; f282; Immune globulin G; Immunoglobulin G; Myristica fragrans; Point in time; QNT; Quan; Quant; Quantitative; Random; Rf282; Serum; SR 2.73 1.0h(2)               [arb'U]/mL       0
75270-9 Promethazine PrThr Ser/Plas/Urine Pt Ord Screen   ACTIVE Promethazine [Presence] in Serum or Plasma or Urine by Screen method   MIN DefinitionDescription                   DRUG/TOX   75270-9   Screen     Both       0 Promethazine Ser/Plas/Urn Ql Scn           Atosil; Avomine; DRUG/TOXICOLOGY; Drugs; Fargan; Farganesse; Lergigan; Ordinal; Phenergan; Pl; Plasma; Plsm; Point in time; PR; Promethegan; Prothiazine; QL; Qual; Qualitative; Random; Receptozine; Romergan; Scn; Scr; Screen; Scrn; Ser/Plas/Urn; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sominex; SR; UA; UR; Urn 2.73 2.5                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
75271-7 Other cells/Cells NFr Lymph node Pt Qn Manual count   ACTIVE Other cells/cells in Lymph node by Manual count   NAM DefinitionDescription     %             HEM/BC   75271-7   Manual count     Both       0 Other cells NFr LN Manual           Cell; Cellularity; HEMATOLOGY/CELL COUNTS; LN; Manl; Number fraction; Othr; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random 2.79 2.5               %     Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; 0
75272-5 Age at event onset Time ^Patient Pt Qn     ACTIVE Age at event onset   MIN DefinitionDescription     years             HL7.CCDA   75272-5         Observation       0 Age at onset           Age at onset; HL7CCDA; Point in time; QNT; Quan; Quant; Quantitative; Random 2.56 2.5               a     Removed method of "HL7CCDAR2" because this term is not an HL7 C-CDA-specific concept and can be used in various use-cases. 0
75273-3 Age at event onset Time ^Family member Pt Qn     ACTIVE Age at event onset Family member   MIN DefinitionDescription     years             HL7.CCDA   75273-3         Observation       0 Age at onset Fam Mem           Age at onset; Fam Mem; HL7CCDA; Point in time; QNT; Quan; Quant; Quantitative; Random 2.56 2.5               a     Removed method of "HL7CCDAR2" because this term is not an HL7 C-CDA-specific concept and can be used in various use-cases. 0
75274-1 Characteristics of residence Find ^Patient Pt Nom     ACTIVE Characteristics of residence   MIN DefinitionDescription                   HL7.CCDA   75274-1         Observation       0 Charact of residence           Charact of residence; Characteristics of home environment; environment; Finding; Findings; HL7CCDA; home; home environment; Housing; Living Arrangement; Living Arrangements; Nominal; Point in time; Random; SDOH 2.56 2.5                     Removed method of "HL7CCDAR2" since this concept is not bound to the C-CDA guide and can be used in various use-cases. 0
75275-8 Cognitive function Imp ^Patient Pt Nom     ACTIVE Cognitive function [Interpretation]   MIN DefinitionDescription       p           HL7.CCDA   75275-8         Observation       0 Cogn func Imp           Cogn func; cognition; cognitive status; FCN; Func; Funct; HL7CCDA; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Point in time; Random 2.61 2.5                     Changed the method from "HL7CCDAR2" since this term is not bound to the guide and can be used in various use-cases. Changed Property from "Find" to "Imp" since this observation is a record of the patient's cognitive function assessment. 0
75276-6 Functional status Imp ^Patient Pt Nom     ACTIVE Functional status [Interpretation]   MIN DefinitionDescription                   HL7.CCDA   75276-6         Observation       0 Functional status Imp           HL7CCDA; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Point in time; Random 2.56 2.5                     Removed method of "HL7CCDAR2" since this concept is not bound to the guide and can be used in various use-cases. Changed Property from "Find" to "Imp" since this observation is a record of the patient's functional status assessment. 0
104,672 results found